Related Experiment Video
Updated: Jun 17, 2026
08:01
Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
A single-point mutation in FGFR2 affects cell cycle and Tgfbeta signalling in osteoblasts.
Kingyin M A Lee1, Leonor Santos-Ruiz, Patrizia Ferretti
1Developmental Biology Unit, UCL Institute of Child Health, London University College London, London WC1N1EH, UK.
Biochimica Et Biophysica Acta
|December 17, 2009
Summary
Fibroblast growth factor (FGF) and Transforming growth factor-beta (TGF-β) signaling regulate bone development. This study reveals a Crouzon syndrome mutation impairs osteoblast response to TGF-β, impacting bone growth.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cell Biology
Background:
- Fibroblast growth factor (FGF) and Transforming growth factor-beta (TGF-β) are crucial for bone development.
- Cranial suture fusion defects are linked to FGF signaling issues, but the relationship with TGF-β signaling is unclear.
Purpose of the Study:
- To investigate the effects of a specific FGF receptor 2 (FGFR2) mutation (hFGFR2-C278F), associated with Crouzon and Pfeiffer syndromes, on osteoblast function.
- To explore the interplay between FGF and TGF-β signaling pathways in the context of this mutation.
Main Methods:
- Utilized mouse calvaria osteoblasts with the hFGFR2-C278F mutation.
- Assessed cell proliferation (S-phase), apoptosis, differentiation, and gene expression.
- Investigated the role of TGF-β and Erk1/2 signaling pathways.
Main Results:
- Mutated osteoblasts showed reduced proliferation, increased apoptosis, and enhanced differentiation.
- TGF-β expression was decreased in mutated cells.
- Mutated osteoblasts failed to respond to TGF-β stimulation for proliferation, unlike controls, and exhibited altered Erk1/2 signaling.
Conclusions:
- The hFGFR2-C278F mutation impairs osteoblast response to TGF-β via the Erk pathway.
- This suggests a loss-of-function mechanism contributing to premature cranial suture fusion in related syndromes.
Related Concept Videos
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:54Canonical Wnt Signaling Pathway
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...